295 related articles for article (PubMed ID: 22110693)
21. Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice.
Angulo I; de las Heras FG; García-Bustos JF; Gargallo D; Muñoz-Fernández MA; Fresno M
Blood; 2000 Jan; 95(1):212-20. PubMed ID: 10607705
[TBL] [Abstract][Full Text] [Related]
22. A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion.
Hara T; Katakai T; Lee JH; Nambu Y; Nakajima-Nagata N; Gonda H; Sugai M; Shimizu A
Int Immunol; 2006 Feb; 18(2):301-11. PubMed ID: 16410312
[TBL] [Abstract][Full Text] [Related]
23. Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools.
Valencia J; Jiménez E; Martínez VG; Del Amo BG; Hidalgo L; Entrena A; Fernández-Sevilla LM; Del Río F; Varas A; Vicente Á; Sacedón R
Cytotherapy; 2017 May; 19(5):640-653. PubMed ID: 28262465
[TBL] [Abstract][Full Text] [Related]
24. Neonatal lymph node stromal cells drive myelodendritic lineage cells into a distinct population of CX3CR1+CD11b+F4/80+ regulatory macrophages in mice.
Zhang X; Yu S; Hoffmann K; Yu K; Förster R
Blood; 2012 Apr; 119(17):3975-86. PubMed ID: 22403256
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses.
Bonham CA; Lu L; Li Y; Hoffman RA; Simmons RL; Thomson AW
Transplantation; 1996 Dec; 62(12):1871-7. PubMed ID: 8990379
[TBL] [Abstract][Full Text] [Related]
26. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma.
Karpuzoglu E; Fenaux JB; Phillips RA; Lengi AJ; Elvinger F; Ansar Ahmed S
Endocrinology; 2006 Feb; 147(2):662-71. PubMed ID: 16293660
[TBL] [Abstract][Full Text] [Related]
27. Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling.
Brown FD; Sen DR; LaFleur MW; Godec J; Lukacs-Kornek V; Schildberg FA; Kim HJ; Yates KB; Ricoult SJH; Bi K; Trombley JD; Kapoor VN; Stanley IA; Cremasco V; Danial NN; Manning BD; Sharpe AH; Haining WN; Turley SJ
Nat Immunol; 2019 Dec; 20(12):1668-1680. PubMed ID: 31636464
[TBL] [Abstract][Full Text] [Related]
28. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
[TBL] [Abstract][Full Text] [Related]
29. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
Liu Z; Fan H; Wu Y; Chen B
Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457
[TBL] [Abstract][Full Text] [Related]
30. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
31. Fibroblastic reticular cell response to dendritic cells requires coordinated activity of podoplanin, CD44 and CD9.
de Winde CM; Makris S; Millward LJ; Cantoral-Rebordinos JA; Benjamin AC; Martínez VG; Acton SE
J Cell Sci; 2021 Jul; 134(14):. PubMed ID: 34184727
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cell-derived nitric oxide inhibits the differentiation of effector dendritic cells.
Si C; Zhang R; Wu T; Lu G; Hu Y; Zhang H; Xu F; Wei P; Chen K; Tang H; Yeretssian G; Xiong H
Oncotarget; 2016 Nov; 7(46):74834-74845. PubMed ID: 27556858
[TBL] [Abstract][Full Text] [Related]
33. Tetrahydro-4-aminobiopterin attenuates dendritic cell-induced T cell priming independently from inducible nitric oxide synthase.
Thoeni G; Stoitzner P; Brandacher G; Romani N; Heufler C; Werner-Felmayer G; Werner ER
J Immunol; 2005 Jun; 174(12):7584-91. PubMed ID: 15944258
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast-type reticular stromal cells regulate the lymph node vasculature.
Chyou S; Ekland EH; Carpenter AC; Tzeng TC; Tian S; Michaud M; Madri JA; Lu TT
J Immunol; 2008 Sep; 181(6):3887-96. PubMed ID: 18768843
[TBL] [Abstract][Full Text] [Related]
35. IFNAR signaling in fibroblastic reticular cells can modulate CD8
Knop L; Spanier J; Larsen PK; Witte A; Bank U; Dunay IR; Kalinke U; Schüler T
Eur J Immunol; 2022 Jun; 52(6):895-906. PubMed ID: 35365883
[TBL] [Abstract][Full Text] [Related]
36. pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.
Ozga AJ; Moalli F; Abe J; Swoger J; Sharpe J; Zehn D; Kreutzfeldt M; Merkler D; Ripoll J; Stein JV
J Exp Med; 2016 Nov; 213(12):2811-2829. PubMed ID: 27799622
[TBL] [Abstract][Full Text] [Related]
37. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.
Mueller SN; Matloubian M; Clemens DM; Sharpe AH; Freeman GJ; Gangappa S; Larsen CP; Ahmed R
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15430-5. PubMed ID: 17878315
[TBL] [Abstract][Full Text] [Related]
38. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
39. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis.
Kania G; Siegert S; Behnke S; Prados-Rosales R; Casadevall A; Lüscher TF; Luther SA; Kopf M; Eriksson U; Blyszczuk P
Circulation; 2013 Jun; 127(23):2285-94. PubMed ID: 23671208
[TBL] [Abstract][Full Text] [Related]
40. Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
Hennies CM; Reboulet RA; Garcia Z; Nierkens S; Wolkers MC; Janssen EM
Clin Exp Immunol; 2011 Mar; 163(3):381-91. PubMed ID: 21235535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
